Machine Learning

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

With a strong cash runway and pivotal trials underway, Sionna Therapeutics aims to revolutionize CF treatment with a novel class of NBD1 stabilizer drugs.

As childhood nearsightedness soars, a new contact lens offers hope by not just correcting vision but actively slowing its progression in key global markets.

Qubic has released Neuraxon 2.0, a bio-inspired framework using trinary logic to create 'LiveAIs' that adapt in real time, challenging static 'DeadLLMs'.

Hopes for a new Huntington's gene therapy face a major delay as the FDA rejects uniQure's current data and calls for a more rigorous, complex study.

Space42 and Viasat's new venture, Equatys, aims to connect billions with a neutral, shared satellite network, challenging rivals like Starlink and AST.

RIB Software's virtual event will gather global experts to explore how AI and connected data are tackling fragmentation and reshaping the AEC industry.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

At MWC 2026, pureLiFi unveiled a new device to solve 5G's indoor signal woes and demonstrated a staggering 10 Gbps LiFi connection.

HARMAN's new rugged platform brings automotive-grade safety, security, and infotainment to two-wheelers, targeting a market ripe for a tech overhaul.

At MWC Barcelona, Qualcomm revealed a massive coalition aiming to build an AI-native 6G network, setting the stage for a new era of intelligent connectivity.

At MWC 2026, MaxLinear showcases a single-chip solution enabling smaller, greener 5G radios, tackling key hurdles in the promising Open RAN market.

TCL announces its award-winning NXTPAPER 70 Pro is coming to the US, boasting a revolutionary paper-like display designed to combat digital eye strain.

Mimosa Networks unveils new NLOS radios and a licensed spectrum strategy, targeting hard-to-reach areas and reshaping the fixed wireless broadband market.

Shareholder approval paves the way for cancer therapy innovator VERAXA to go public, aiming to accelerate its next-gen antibody-drug conjugate pipeline.

Motorola's new Razr Fold boasts a top-tier camera, massive battery, and 7-year support. Can it dethrone Samsung and redefine the foldable market?

A new dating app, QingTengZhiLian HK, promises to end swipe fatigue with psychology and AI. But can an algorithm truly engineer love in a crowded market?

Following high-grade discoveries, North Arrow launches a $2.3M campaign using advanced tech to unlock a potentially vast gold district in Botswana.

With its new AI thriller, muVpix is betting on 'engineered storytelling' to finally crack the vertical video code that doomed giants like Quibi.